Companies / Cogent Biosciences
Cogent Biosciences
United States
Cogent Biosciences conducts clinical trials and develops treatments for diseases such as Systemic Mastocytosis and Gastrointestinal Stromal Tumors.
Cogent Biosciences, based in United States, has 1 investor on file, among them Atlas Venture. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
In the news
3 headlines naming Cogent BiosciencesEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from Atlas Venture
52 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (93%), Industrial & Manufacturing (2%), Robotics & Hardware (2%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Cogent Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Atlas Venture adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/cogentbio.com/investors
# also
GET /v1/companies/cogentbio.com
GET /v1/companies/cogentbio.com/news